Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DRD4 | P21917 | 1/20 | 0.51 |
| ▸ | IKBKB | O14920 | 1/20 | 0.50 |
| ▸ | MEN1 | O00255 | 5/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.48 |
| ▸ | MAPT | P10636 | 3/20 | 0.47 |
| ▸ | POLB | P06746 | 2/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
| ▸ | GLA | P06280 | 1/20 | 0.47 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.47 |
| ▸ | THRB | P10828 | 1/20 | 0.47 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.47 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.47 |
| ▸ | NR1H4 | Q96RI1 | 2/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.43 |
| ▸ | NPC1 | O15118 | 4/20 | 0.43 |
| ▸ | RAB9A | P51151 | 4/20 | 0.43 |
| ▸ | TP53 | P04637 | 1/20 | 0.43 |
| ▸ | MAOA | P21397 | 1/20 | 0.43 |
| ▸ | MAOB | P27338 | 1/20 | 0.43 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL449460 | 1.00 | DRD4 (0.51) | DRD4IKBKBMEN1KMT2AMAPT | |
| SCHEMBL5580414 | 0.80 | CCR3 (0.48) | MEN1KMT2AMAPT | |
| SCHEMBL5580412 | 0.80 | CCR3 (0.48) | MEN1KMT2AMAPT | |
| SCHEMBL22505235 | 0.77 | HDAC3 (0.52) | MEN1KMT2ANR1H4SMN1; SMN2NPC1 | |
| SCHEMBL6410116 | 0.75 | SMN1; SMN2 (0.72) | DRD4IKBKBMEN1KMT2AMAPT | |
| SCHEMBL3936107 | 0.71 | NPC1 (0.49) | MEN1KMT2AMAPTPOLBKDM4E | |
| SCHEMBL3936101 | 0.71 | NPC1 (0.49) | MEN1KMT2AMAPTPOLBKDM4E | |
| SCHEMBL11327905 | 0.71 | ALDH1A1 (0.42) | MEN1KMT2AMAPTKDM4ETHRB | |
| SCHEMBL1309030 | 0.71 | GAA (0.48) | MEN1KMT2AMAPTPOLBTHRB | |
| SCHEMBL1309087 | 0.71 | GAA (0.48) | MEN1KMT2AMAPTPOLBTHRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8592482-B2 | CCR3 inhibition for ocular angiogenesis and macular degeneration | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION (US) | 2013-11-26 | — | — | US | claimed |
| US-20110268723-A1 | CCR3 Inhibition for Ocular Angiogenesis and Macular Degeneration | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION (US) | 2011-11-03 | — | — | US | claimed |
| US-20090123375-A1 | CCR3 Inhibition for Ocular Angiogenesis and Macular Degeneration | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION (US) | 2009-05-14 | — | — | US | claimed |
| WO-2007098113-A2 | CCR3 INHIBITION FOR OCULAR ANGIOGENESIS AND MACULAR DEGENERATION | UNIVERSITY OF KENTUCKY (US) | 2007-08-30 | — | — | WO | claimed |
| US-20240191238-A1 | BIOMARKERS OF AGING FOR DETECTION AND TREATMENT OF DISORDERS | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY | 2024-06-13 | — | — | US | disclosed |
| US-11912998-B2 | Method of treating aging-associated cognitive impairment by reducing CCR3 | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2024-02-27 | — | — | US | disclosed |
| US-20220213487-A1 | CCR3 MODULATION IN THE TREATMENT OF AGING-ASSOCIATED IMPAIRMENTS, AND COMPOSITIONS FOR PRACTICING THE SAME | THE UNITED STATES GOVERNMENT AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS | 2022-07-07 | — | — | US | disclosed |
| US-11345756-B2 | CCR3 inhibition for ocular angiogenesis and macular degeneration | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION (US) | 2022-05-31 | — | — | US | disclosed |
| US-11236340-B2 | Method of reducing the effects of aging-associated impairment of neurogenesis comprising modulating c-c chemokine receptor type 3 (CCR3) | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2022-02-01 | — | — | US | disclosed |
| US-20200399644-A1 | CCR3 MODULATION IN THE TREATMENT OF AGING-ASSOCIATED IMPAIRMENTS, AND COMPOSITIONS FOR PRACTICING THE SAME | THE UNITED STATES GOVERNMENT AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS | 2020-12-24 | — | — | US | disclosed |
| US-10626399-B2 | Methods of treating cognitive symptoms of an aging-associated impairment by modulating C-C chemokine receptor type 3 (CCR3) | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2020-04-21 | — | — | US | disclosed |
| US-20200054745-A1 | METHODS FOR TREATMENT OF AGE-RELATED MACULAR DEGENERATION | LASHKARI KAMERAN (US) | 2020-02-20 | — | — | US | disclosed |
| US-20120064010-A1 | CCR3 and its Ligands Are Therapeutic and Diagnostic Targets for Neovascular Age-Related Macular Degeneration | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION (US) | 2012-03-15 | — | — | US | disclosed |
| US-20110268723-A1 | CCR3 Inhibition for Ocular Angiogenesis and Macular Degeneration | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION (US) | 2011-11-03 | — | — | US | disclosed |
| US-8008092-B2 | CCR3 inhibition for ocular angiogenesis and macular degeneration | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION (US) | 2011-08-30 | — | — | US | disclosed |
| WO-2010138591-A1 | CCR3 AND ITS LIGANDS ARE THERAPEUTIC AND DIAGNOSTIC TARGETS FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION (US) | 2010-12-02 | — | — | WO | disclosed |
| WO-2010129351-A1 | METHOD TO IDENTIFY AND TREAT AGE-RELATED MACULAR DEGENERATION | SCHEPENS EYE RESEARCH INSTITUTE (US) | 2010-11-11 | — | — | WO | disclosed |
| US-20090123375-A1 | CCR3 Inhibition for Ocular Angiogenesis and Macular Degeneration | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION (US) | 2009-05-14 | — | — | US | disclosed |
| WO-2007098113-A2 | CCR3 INHIBITION FOR OCULAR ANGIOGENESIS AND MACULAR DEGENERATION | UNIVERSITY OF KENTUCKY (US) | 2007-08-30 | — | — | WO | disclosed |
| US-20070190055-A1 | CCR3 inhibition for ocular angiogenesis and macular degeneration | KENTUCKY RESEARCH FOUNDATION, UNIVERSITY OF | 2007-08-16 | — | — | US | disclosed |